A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken with Rosuvastatin

Trial Identifier:	15994
Sponsor:	AstraZeneca
Collaborator:	Eli Lilly and Company
NCTID::	NCT03019549
Start Date:	January 2017
Primary Completion Date:	May 2017
Study Completion Date:	May 2017
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States, Florida	Daytona Beach, Florida, United States, 32117

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.